NO20081729L - Nye diazaspiroalkaner og deres anvendelse for behandling av CCR8-medierte sykdommer - Google Patents
Nye diazaspiroalkaner og deres anvendelse for behandling av CCR8-medierte sykdommerInfo
- Publication number
- NO20081729L NO20081729L NO20081729A NO20081729A NO20081729L NO 20081729 L NO20081729 L NO 20081729L NO 20081729 A NO20081729 A NO 20081729A NO 20081729 A NO20081729 A NO 20081729A NO 20081729 L NO20081729 L NO 20081729L
- Authority
- NO
- Norway
- Prior art keywords
- treatment
- diazaspiroalkanes
- ccr8
- new
- mediated diseases
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pulmonology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Otolaryngology (AREA)
- Epidemiology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0501967 | 2005-09-06 | ||
PCT/SE2006/001012 WO2007030061A1 (en) | 2005-09-06 | 2006-09-04 | Novel diazaspiroalkanes and their use for treatment of ccr8 mediated diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20081729L true NO20081729L (no) | 2008-05-16 |
Family
ID=37836107
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20081729A NO20081729L (no) | 2005-09-06 | 2008-04-07 | Nye diazaspiroalkaner og deres anvendelse for behandling av CCR8-medierte sykdommer |
Country Status (17)
Country | Link |
---|---|
US (1) | US20090156575A1 (ja) |
EP (1) | EP1926730A4 (ja) |
JP (1) | JP2009507070A (ja) |
KR (1) | KR20080043396A (ja) |
CN (1) | CN101305005A (ja) |
AR (1) | AR055630A1 (ja) |
AU (1) | AU2006287976A1 (ja) |
BR (1) | BRPI0615634A2 (ja) |
CA (1) | CA2621187A1 (ja) |
EC (1) | ECSP088329A (ja) |
IL (1) | IL189528A0 (ja) |
NO (1) | NO20081729L (ja) |
RU (1) | RU2008110915A (ja) |
TW (1) | TW200800999A (ja) |
UY (1) | UY29781A1 (ja) |
WO (1) | WO2007030061A1 (ja) |
ZA (1) | ZA200801511B (ja) |
Families Citing this family (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7378525B2 (en) | 2002-12-23 | 2008-05-27 | Millennium Pharmaceuticals, Inc. | CCR8 inhibitors |
TW200510311A (en) | 2002-12-23 | 2005-03-16 | Millennium Pharm Inc | CCr8 inhibitors |
US7491827B2 (en) | 2002-12-23 | 2009-02-17 | Millennium Pharmaceuticals, Inc. | Aryl sulfonamides useful as inhibitors of chemokine receptor activity |
AR074760A1 (es) | 2008-12-18 | 2011-02-09 | Metabolex Inc | Agonistas del receptor gpr120 y usos de los mismos en medicamentos para el tratamiento de diabetes y el sindrome metabolico. |
WO2010070032A1 (en) | 2008-12-19 | 2010-06-24 | Boehringer Ingelheim International Gmbh | Cyclic pyrimidin-4-carboxamides as ccr2 receptor antagonists for treatment of inflammation, asthma and copd |
US8796297B2 (en) | 2009-06-30 | 2014-08-05 | Abbvie Inc. | 4-substituted-2-amino-pyrimidine derivatives |
KR101509809B1 (ko) * | 2009-12-01 | 2015-04-08 | 현대자동차주식회사 | 차량의 커튼에어백용 램프브라켓 |
PT3091012T (pt) * | 2009-12-17 | 2018-06-27 | Centrexion Therapeutics Corp | Antagonistas do receptor ccr2 e suas utilizações |
US8815869B2 (en) | 2010-03-18 | 2014-08-26 | Abbvie Inc. | Lactam acetamides as calcium channel blockers |
WO2011151251A1 (en) | 2010-06-01 | 2011-12-08 | Boehringer Ingelheim International Gmbh | New ccr2 antagonists |
CN102267995A (zh) * | 2010-06-04 | 2011-12-07 | 艾琪康医药科技(上海)有限公司 | 一种制备二氮杂螺环化合物的方法 |
US8299117B2 (en) | 2010-06-16 | 2012-10-30 | Metabolex Inc. | GPR120 receptor agonists and uses thereof |
DK2582674T3 (en) | 2010-06-16 | 2014-12-15 | Cymabay Therapeutics Inc | GPR120 receptor agonists and uses thereof. |
CN102796100B (zh) * | 2011-05-27 | 2015-05-06 | 中国医学科学院医药生物技术研究所 | 一种取代苯基-(二氮杂螺环-n)-甲酮类衍生物 |
EP2641903B1 (de) * | 2012-03-19 | 2014-10-22 | Symrise AG | Dihydrobenzofuran-Derivate als Riech- und/oder Aromastoffe |
NZ702334A (en) * | 2012-06-13 | 2016-11-25 | Hoffmann La Roche | New diazaspirocycloalkane and azaspirocycloalkane |
SG11201500572YA (en) | 2012-09-25 | 2015-02-27 | Hoffmann La Roche | New bicyclic derivatives |
CN102942570A (zh) * | 2012-12-05 | 2013-02-27 | 武汉药明康德新药开发有限公司 | 1-三氟甲基-2,8-二氮杂-螺[4.5]癸烷衍生物及其制备方法 |
AR095079A1 (es) | 2013-03-12 | 2015-09-16 | Hoffmann La Roche | Derivados de octahidro-pirrolo[3,4-c]-pirrol y piridina-fenilo |
MA38982A1 (fr) | 2013-11-26 | 2017-09-29 | Hoffmann La Roche | Nouvel octahydro-cyclobuta [1,2-c; 3,4-c'] dipyrrol-2-yl |
EP3122751B1 (en) | 2014-03-26 | 2019-10-30 | F.Hoffmann-La Roche Ag | Condensed [1,4]diazepine compounds as autotaxin (atx) and lysophosphatidic acid (lpa) production inhibitors |
UA118582C2 (uk) | 2014-03-26 | 2019-02-11 | Ф. Хоффманн-Ля Рош Аг | Біциклічні сполуки як інгібітори продукції аутотаксину (atx) і лізофосфатидилової кислоти (lpa) |
CA2955071A1 (en) | 2014-07-15 | 2016-01-21 | Grunenthal Gmbh | Substituted azaspiro(4.5)decane derivatives |
TW201607923A (zh) | 2014-07-15 | 2016-03-01 | 歌林達有限公司 | 被取代之氮螺環(4.5)癸烷衍生物 |
JP6601707B2 (ja) * | 2015-02-15 | 2019-11-06 | 国立大学法人金沢大学 | 線維化判定方法 |
MA41898A (fr) | 2015-04-10 | 2018-02-13 | Hoffmann La Roche | Dérivés de quinazolinone bicyclique |
PL3317270T3 (pl) | 2015-07-02 | 2020-11-16 | Centrexion Therapeutics Corporation | Cytrynian (4-((3r,4r)-3-metoksytetrahydropiran-4-yloamino)piperydyn-1-ylo)(5-metylo-6-(((2r,6s)-6-(p-tolilo)tetrahydro-2h-piran-2-ylo)metylamino)pirymidyn-4-ylo)metanonu |
MX2018000511A (es) | 2015-09-04 | 2018-04-24 | Hoffmann La Roche | Derivados de fenoximetilo. |
JP6846414B2 (ja) | 2015-09-24 | 2021-03-24 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | Atx阻害剤としての二環式化合物 |
KR20180054634A (ko) | 2015-09-24 | 2018-05-24 | 에프. 호프만-라 로슈 아게 | 이중 오토탁신(atx)/탄산 무수화효소(ca) 억제제로서 신규한 이환형 화합물 |
AU2016328365B2 (en) | 2015-09-24 | 2020-04-23 | F. Hoffmann-La Roche Ag | New bicyclic compounds as dual ATX/CA inhibitors |
RU2018112230A (ru) | 2015-09-24 | 2019-10-30 | Ф. Хоффманн-Ля Рош Аг | Бициклические соединения в качестве ингибиторов atx |
CN106908559B (zh) * | 2015-12-23 | 2020-08-11 | 重庆华邦胜凯制药有限公司 | 卡泊三醇中间体l及相关杂质的分离与测定方法 |
JP7097358B2 (ja) * | 2016-11-08 | 2022-07-07 | ブリストル-マイヤーズ スクイブ カンパニー | アルファvインテグリン阻害剤としての3-置換プロピオン酸 |
CN108456208B (zh) * | 2017-02-22 | 2021-04-16 | 广州市恒诺康医药科技有限公司 | 氮杂螺环类化合物及其制备方法和应用 |
CN106928092B (zh) * | 2017-02-28 | 2019-02-15 | 上海微巨实业有限公司 | 一种间氰甲基苯甲酸甲酯的制备方法 |
CA3053329A1 (en) | 2017-03-16 | 2018-09-20 | F. Hoffmann-La Roche Ag | Heterocyclic compounds useful as dual atx/ca inhibitors |
WO2018166855A1 (en) | 2017-03-16 | 2018-09-20 | Basf Se | Heterobicyclic substituted dihydroisoxazoles |
WO2018167113A1 (en) | 2017-03-16 | 2018-09-20 | F. Hoffmann-La Roche Ag | New bicyclic compounds as atx inhibitors |
WO2019084075A1 (en) * | 2017-10-24 | 2019-05-02 | The Trustees Of The University Of Pennsylvania | DOPAMINE RECEPTOR SELECTIVE ANTAGONISTS AND METHODS OF USING THE SAME |
JP2021516229A (ja) | 2018-02-28 | 2021-07-01 | ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア | 低親和性ポリ(ad−リボース)ポリメラーゼ1依存性細胞毒性剤 |
WO2020048827A1 (en) | 2018-09-03 | 2020-03-12 | Bayer Aktiengesellschaft | 1, 3, 9-triazaspiro[5.5] undecan-2-one compounds |
AR116020A1 (es) | 2018-09-03 | 2021-03-25 | Bayer Ag | COMPUESTOS DE 3,9-DIAZAESPIRO[5.5]UNDECANO COMO INHIBIDORES DE GGTasa I Y SU USO PARA EL TRATAMIENTO DE ENFERMEDADES HIPERPROLIFERATIVAS |
WO2020048828A1 (en) | 2018-09-03 | 2020-03-12 | Bayer Pharma Aktiengesellschaft | 5-heteroaryl-3,9-diazaspiro[5.5]undecane compounds |
CN110963955A (zh) * | 2018-09-30 | 2020-04-07 | 南京富润凯德生物医药有限公司 | 一种单氟代螺环化合物的合成方法及其中间体 |
CN111087336A (zh) * | 2018-10-24 | 2020-05-01 | 南京富润凯德生物医药有限公司 | 一种双氟代螺环化合物的合成方法及其中间体 |
AU2020393384A1 (en) | 2019-11-28 | 2022-06-09 | Bayer Aktiengesellschaft | Substituted aminoquinolones as DGKalpha inhibitors for immune activation |
US20230064809A1 (en) | 2019-11-28 | 2023-03-02 | Bayer Aktiengesellschaft | Substituted aminoquinolones as dgkalpha inhibitors for immune activation |
CN115989223A (zh) * | 2020-07-03 | 2023-04-18 | 南京艾美斐生物医药科技有限公司 | 使用CCR8抑制剂靶向Tregs的方法和组合物 |
US20240174680A1 (en) | 2021-01-29 | 2024-05-30 | Cedilla Therapeutics, Inc. | Cdk2 inhibitors and methods of using the same |
IL309571A (en) | 2021-06-26 | 2024-02-01 | Cedilla Therapeutics Inc | CDK2 inhibitors and methods of using them |
CN113717180A (zh) * | 2021-10-15 | 2021-11-30 | 安徽大学 | 一种2-Boc-2,7-二氮杂-螺[4,4]壬烷的合成方法 |
WO2024115549A1 (en) | 2022-11-30 | 2024-06-06 | Idorsia Pharmaceuticals Ltd | Aryl- and heteroaryl-sulfonamide derivatives as ccr8 modulators |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0302811D0 (sv) * | 2003-10-23 | 2003-10-23 | Astrazeneca Ab | Novel compounds |
US20070275990A1 (en) * | 2003-11-13 | 2007-11-29 | Ono Pharmaceutical Co., Ltd. | Heterocyclic Spiro Compound |
CA2546147A1 (en) * | 2003-12-23 | 2005-07-14 | Arena Pharmaceuticals, Inc. | Novel spiroindoline or spiroisoquinoline compounds, methods of use and compositions thereof |
GB2415657A (en) * | 2004-06-18 | 2006-01-04 | Kenwood Marks Ltd | Cutting device for pasta making attachment to a multi-purpose kitchen machine |
GB0601402D0 (en) * | 2006-01-24 | 2006-03-08 | Syngenta Participations Ag | Chemical Compounds |
-
2006
- 2006-08-25 TW TW095131396A patent/TW200800999A/zh unknown
- 2006-09-04 KR KR1020087008256A patent/KR20080043396A/ko not_active Application Discontinuation
- 2006-09-04 JP JP2008529954A patent/JP2009507070A/ja active Pending
- 2006-09-04 CA CA002621187A patent/CA2621187A1/en not_active Abandoned
- 2006-09-04 BR BRPI0615634-7A patent/BRPI0615634A2/pt not_active IP Right Cessation
- 2006-09-04 US US12/065,822 patent/US20090156575A1/en not_active Abandoned
- 2006-09-04 AU AU2006287976A patent/AU2006287976A1/en not_active Abandoned
- 2006-09-04 CN CNA2006800413949A patent/CN101305005A/zh active Pending
- 2006-09-04 WO PCT/SE2006/001012 patent/WO2007030061A1/en active Application Filing
- 2006-09-04 EP EP06784143A patent/EP1926730A4/en not_active Withdrawn
- 2006-09-04 RU RU2008110915/04A patent/RU2008110915A/ru not_active Application Discontinuation
- 2006-09-05 UY UY29781A patent/UY29781A1/es unknown
- 2006-09-06 AR ARP060103885A patent/AR055630A1/es unknown
-
2008
- 2008-02-14 IL IL189528A patent/IL189528A0/en unknown
- 2008-02-14 ZA ZA200801511A patent/ZA200801511B/xx unknown
- 2008-03-28 EC EC2008008329A patent/ECSP088329A/es unknown
- 2008-04-07 NO NO20081729A patent/NO20081729L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
US20090156575A1 (en) | 2009-06-18 |
JP2009507070A (ja) | 2009-02-19 |
CA2621187A1 (en) | 2007-03-15 |
AU2006287976A1 (en) | 2007-03-15 |
ZA200801511B (en) | 2008-11-26 |
AR055630A1 (es) | 2007-08-29 |
TW200800999A (en) | 2008-01-01 |
CN101305005A (zh) | 2008-11-12 |
BRPI0615634A2 (pt) | 2011-05-24 |
KR20080043396A (ko) | 2008-05-16 |
RU2008110915A (ru) | 2009-10-20 |
EP1926730A1 (en) | 2008-06-04 |
WO2007030061A1 (en) | 2007-03-15 |
IL189528A0 (en) | 2008-08-07 |
EP1926730A4 (en) | 2011-02-16 |
UY29781A1 (es) | 2007-04-30 |
ECSP088329A (es) | 2008-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20081729L (no) | Nye diazaspiroalkaner og deres anvendelse for behandling av CCR8-medierte sykdommer | |
NO20081217L (no) | Nye benzotiazolonderivater | |
NO20073572L (no) | Nye forbindelser | |
NO20054329L (no) | Adamantanderivater, fremgangsmater for deres fremstilling og farmasoytiske sammensetninger som innbefatter slike | |
NO20065456L (no) | Substituerte morfolinforbindelser for behandling av sykdommer i sentralnervesystemet | |
NO20092412L (no) | Hydantoinderivater anvendes som MMP-inhibitorer | |
NO20071504L (no) | Pyrimidinderivanter. | |
NO20074275L (no) | 2- (4-okso-4H-kinazolin-3-yl) acetamider og deres anvendelse som Vasopressin-V3-antagonister | |
NO20090628L (no) | Pyridizinon derivativater | |
NO20080675L (no) | P38-Map kinaseinhibitorer og metoder for deres anvendelse | |
NO20076059L (no) | 2,4-Diamino-pyrimidiner anvendt som aurorainhibitorer | |
NO20071776L (no) | Kinoksaliner som B RAF inhibitorer. | |
NO20071246L (no) | Kinazolinonderivater og deres anvendelse som B-RAF-inhibitorer. | |
TW200738659A (en) | Novel compounds | |
NO20074592L (no) | Acetylenyl-pyrazolo-pyrimidinderivater som mGluR2-antagonister | |
NO20073101L (no) | Nye pyridinforbindelser | |
NO20073859L (no) | Pyrrolopyrazoler, potente kinaseinhibitorer | |
TW200801003A (en) | Novel compounds | |
TW200745084A (en) | Novel compounds | |
NO20083845L (no) | 2,4-diaminopyrimidiner som celle-cyklus kinase inhibitorer | |
NO20073571L (no) | Nye hydantoinderivater som metallproteinaseinhibitorer | |
NO20061363L (no) | Pyrazolo- og imidazo- pyrimidinderivater | |
NO20084202L (no) | 4-anilinoquinolin-3-carboksamider som CSF-1R kinase inhibitorer | |
NO20070570L (no) | Forbindelser. | |
NO20071245L (no) | Kinazolinonderivater og deres anvendelse som b-RAF-inhibitorer. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |